EU Strategy Lacks Specific Funding for Alternative Protein Scaling

European Commission's food research strategy for 2028-34 identifies industrial fermentation capacity gaps but omits targeted funding commitments for alternative proteins despite private sector growth.

The European Commission published its food research strategy on September 14, 2026, aiming to guide Horizon Europe food investments from 2028-34. While the strategy acknowledges the need to scale fermentation capacity for alternative proteins, it contains no specific funding commitments for this sector. GFI Europe's analysis of first-half 2026 data shows fermentation firms received 84% of private funding for alternative proteins, amid a 56% year-on-year increase in total private investment. The Commission previously allocated €350 million for food and biotech innovation but the strategy identifies an industrial fermentation capacity gap as a key challenge without addressing it through dedicated funding. The strategy also excludes novel foods from regulatory sandboxes under the EU's Biotech Act, despite referencing agrifood innovation sandboxes.

This omission creates a risk that scaling efforts could face delays without targeted financial support. The sector's rapid private investment growth highlights the market demand, but the absence of Commission-backed funding mechanisms may hinder timely industrial capacity expansion. The strategy's criticism of the 2025 Protein Plan for not supporting protein-rich crop farming adds context to the sector's funding challenges.

What to watch: Horizon Europe implementation decisions (2028-34) and whether the regulatory sandbox exclusion for novel foods will be resolved. The source notes this is based on GFI Europe's H1 2026 analysis and the strategy's timeline for Horizon Europe decisions remains 2028-34. The EU's ban on meat-related terms on plant-based labels also creates labeling friction that could affect consumer adoption.

Source: Green Queen